The firm, launched with a $100m investment by Illumina in April 2016, has added $130m from unnamed external investors.
Illumina Ventures, the strategic venture capital firm formed by genomics technology provider Illumina, increased the size of its first fund from $100m to $230m on Monday.
The firm launched in April 2016 with $100m from Illumina, before raising the rest from undisclosed corporate, sovereign, institutional and individual investors. The fund had reached $189m in size by April this year, according to a regulatory filing.
Although Illumina Ventures is managed independently from Illumina, its focus areas – genomics and precision medicine…
